Emerging Market and Product Entry
Kukuza works with organisations to access the growth and commercial opportunities that exist in emerging markets. We assist them to understand, assess and navigate this complex, dynamic landscape; and then evaluate, plan and implement successful market and product entry strategies.
We have supported a wide range of topics, disease areas and market access sectors.
Market access topics
- Addressable market size
- Market prioritisation (region, country, state/county, city)
- Bespoke interactive prioritisation models (financial, market size)
- Competitors and competitive advantages
- Opportunities for digitisation and disruption
- Customer / patient affordability
- Go-to-market and access plans
- Local partners identification, partner engagement, launch planning
- Supply chain and quality control (incl. cold chain)
- Growth opportunities, challenges and solutions
- Private sector strategy
- Donor / NGO / Public sector engagement
Disease area experience
- Cardiology
- Family planning
- Reproductive health
- Hepatitis
- Infectious disease
- Mental health
- Non-Communicable Disease (NCD)
- Oncology
- Orthopaedic
- Renal
- Vector borne (incl. malaria, dengue)
- Acquired infections
Market access type
- Pharmaceutical products and related services
- Medical devices and diagnostics
- Digitisation of products and process
- Digital innovation and scale
- Manufacturing (pharma, medical devices, vaccines)
- Investment case development
- Affordability and access improvement
- Hospitals and healthcare facilities (PHC, 20 – 450 bed hospitals)
- Education – junior and senior school, academic teaching
Testimonials